These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31238119)

  • 21. Shortening the treatment of tuberculosis.
    Mitchison DA
    Nat Biotechnol; 2005 Feb; 23(2):187-8. PubMed ID: 15696148
    [No Abstract]   [Full Text] [Related]  

  • 22. [Reasons for drug-resistant tuberculosis emergence].
    Tu DH
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
    [No Abstract]   [Full Text] [Related]  

  • 23. Tooth Discoloration in a Patient With Multidrug-Resistant Tuberculosis.
    Clin Infect Dis; 2016 Mar; 62(5):617; 664-5. PubMed ID: 26908847
    [No Abstract]   [Full Text] [Related]  

  • 24. Peripheral neuropathy in a diabetic child treated with linezolid for multidrug-resistant tuberculosis: a case report and review of the literature.
    Swaminathan A; du Cros P; Seddon JA; Mirgayosieva S; Asladdin R; Dusmatova Z
    BMC Infect Dis; 2017 Jun; 17(1):417. PubMed ID: 28606115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Collaborative Approach for "ReSeq-ing" Mycobacterium tuberculosis Drug Resistance: Convergence for Drug and Diagnostic Developers.
    Schito M; Dolinger DL
    EBioMedicine; 2015 Oct; 2(10):1262-5. PubMed ID: 26629499
    [No Abstract]   [Full Text] [Related]  

  • 26. Linezolid resistance in patients with drug-resistant TB.
    Vengurlekar D; Walker C; Mahajan R; Dalal A; Chavan V; Galindo MA; Iyer A; Mansoor H; Silsarma A; Isaakidis P; Spencer H
    Int J Tuberc Lung Dis; 2023 Jul; 27(7):567-569. PubMed ID: 37353865
    [No Abstract]   [Full Text] [Related]  

  • 27. First linezolid-resistant clinical isolates of Mycobacterium tuberculosis.
    Richter E; Rüsch-Gerdes S; Hillemann D
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1534-6. PubMed ID: 17242139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children.
    Rose PC; Hallbauer UM; Seddon JA; Hesseling AC; Schaaf HS
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1588-93. PubMed ID: 23032215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis.
    Park IN; Hong SB; Oh YM; Kim MN; Lim CM; Lee SD; Koh Y; Kim WS; Kim DS; Kim WD; Shim TS
    J Antimicrob Chemother; 2006 Sep; 58(3):701-4. PubMed ID: 16857689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Linezolid in the treatment of multidrug-resistant tuberculosis.
    Schecter GF; Scott C; True L; Raftery A; Flood J; Mase S
    Clin Infect Dis; 2010 Jan; 50(1):49-55. PubMed ID: 19947856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of in vitro synergy between linezolid and other antimicrobial agents against Mycobacterium tuberculosis isolates.
    Zou L; Liu M; Wang Y; Lu J; Pang Y
    Tuberculosis (Edinb); 2015 Dec; 95(6):839-842. PubMed ID: 26395151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bedaquiline.
    Goulooze SC; Cohen AF; Rissmann R
    Br J Clin Pharmacol; 2015 Aug; 80(2):182-4. PubMed ID: 25702772
    [No Abstract]   [Full Text] [Related]  

  • 33. Linezolid in the treatment of MDR-TB: a retrospective clinical study.
    Xu HB; Jiang RH; Li L; Xiao HP
    Int J Tuberc Lung Dis; 2012; 16(3):358-63. PubMed ID: 22640450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction between linezolid and Mycobacterium tuberculosis in an experimental in vitro model.
    Cremades R; Rodríguez JC; Garcia-Pachón E; Galiana A; Ruiz-García M; López P; Royo G
    APMIS; 2011 Apr; 119(4-5):304-8. PubMed ID: 21492231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of moxifloxacin and linezolid during and after pregnancy in a patient with multidrug-resistant tuberculosis.
    Van Kampenhout E; Bolhuis MS; Alffenaar JC; Oswald LM; Kerstjens HA; de Lange WC; van der Werf TS; Akkerman OW
    Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28331037
    [No Abstract]   [Full Text] [Related]  

  • 36. Linezolid for multidrug-resistant tuberculosis: How should we approach it?
    Santin M
    Enferm Infecc Microbiol Clin; 2016 Feb; 34(2):83-4. PubMed ID: 26795055
    [No Abstract]   [Full Text] [Related]  

  • 37. Linezolid for Treating Tuberculosis: A Delicate Balancing Act.
    Maartens G; Benson CA
    EBioMedicine; 2015 Nov; 2(11):1568-9. PubMed ID: 26870767
    [No Abstract]   [Full Text] [Related]  

  • 38. Assessment of the Additional Value of Verapamil to a Moxifloxacin and Linezolid Combination Regimen in a Murine Tuberculosis Model.
    Pieterman ED; Te Brake LHM; de Knegt GJ; van der Meijden A; Alffenaar JC; Bax HI; Aarnoutse RE; de Steenwinkel JEM
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multidrug resistant tuberculosis: a continuing crisis.
    Burki T
    Lancet Infect Dis; 2016 Dec; 16(12):1337-1338. PubMed ID: 27998601
    [No Abstract]   [Full Text] [Related]  

  • 40. Second-line drug susceptibilities of multidrug-resistant tuberculosis strains isolated in Thailand: an update.
    Chaiprasert A; Srimuang S; Tingtoy N; Makhao N; Sirirudeeporn P; Tomnongdee N; Theankeaw O; Charoensook S; Leechawengwongs M; Prammananan T
    Int J Tuberc Lung Dis; 2014 Aug; 18(8):961-3. PubMed ID: 25199012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.